Latest Diamedica News & Updates
See the latest news and media coverage for Diamedica. We track all announcements, press releases, and industry mentions in real time, all in one place.
Safe anaesthesia and respiratory solutions for limited-resource settings
diamedica.co.uk- Headquarters
- Barnstaple, United Kingdom
- Company type
- Private company
- Number of employees
- 5–10
Last updated
Latest news about Diamedica
Company announcements
-
Diamedica showcases DPA03 at WFSA Congress
The device supports disaster relief, emergency response, and rural healthcare. Strong interest draws visitors to their booth.
-
Diamedica launches handheld ultrasonic oxygen analyser for 2026
It measures oxygen in medical gas supplies. In LMICs, it protects patient safety, maximises resources, supports reliable care, and is cost-effective.
-
Diamedica announces Halothane production ceases
Vaporisers labelled for Halothane or Halothane/Isoflurane work with Isoflurane due to similar vapour pressures. Higher settings needed as Isoflurane is less potent.
-
Diamedica supplies emergency medical equipment for Ukraine aid
Diamedica provides portable anaesthetic machines, ventilator, and oxygen concentrator for a mobile hospital near Odesa. Dr. Andrey Varvinskiy praises their generosity and support.
Media coverage
-
DiaMedica outlines ReMEDy2 interim analysis by end of 2026 with potential 300-700 patient resample size
Preeclampsia Part 1a expansion moved from an expectation to finish "in the first half of 2026" previously to "provide a data update later this quarter...
-
DiaMedica Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights - BioSpace
These increases were partially offset by net cost reductions in manufacturing development activity related to work performed and completed in the prior year period. DiaMedica...
-
DiaMedica Therapeutics to Report First Quarter 2026 Financial Results and Provide a Business Update May 7, 2026
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke (AIS...
-
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2025 earnings call transcript
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2025 Earnings Call Transcript March 31, 2026 Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Full...
Track Diamedica and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore